Publicaciones en colaboración con investigadores/as de University of KwaZulu-Natal (23)

2024

  1. Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium

    The Lancet HIV, Vol. 11, Núm. 10, pp. e700-e710

  2. Comparison of Patient Health Questionnaire-9, Edinburgh Postnatal Depression Scale and Hospital Anxiety and Depression – Depression subscale scores by administration mode: An individual participant data differential item functioning meta-analysis

    Journal of Affective Disorders, Vol. 361, pp. 674-683

  3. Impact of Positive Cultures During the Second Stage of a Two-Stage Exchange: Systematic Review and Meta-Analysis

    Journal of Arthroplasty, Vol. 39, Núm. 3, pp. 839-845.e15

  4. Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission

    Nature Medicine, Vol. 30, Núm. 10, pp. 2796-2804

2023

  1. Guideline for management of septic arthritis in native joints (SANJO)

    Journal of Bone and Joint Infection, Vol. 8, Núm. 1, pp. 29-37

  2. Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial

    The Lancet Child and Adolescent Health, Vol. 7, Núm. 10, pp. 718-727

2022

  1. Advancing the prevention and treatment of HIV in children: priorities for research and development

    The lancet. HIV, Vol. 9, Núm. 9, pp. e658-e666

  2. Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial

    BMC Medical Research Methodology, Vol. 22, Núm. 1

  3. Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

    The Lancet HIV, Vol. 9, Núm. 9, pp. e627-e637

  4. Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

    The Lancet HIV, Vol. 9, Núm. 9, pp. e638-e648

  5. What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies

    The Lancet HIV, Vol. 9, Núm. 9, pp. e649-e657

2021

  1. Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

    New England Journal of Medicine, Vol. 385, Núm. 27, pp. 2531-2543

2020

  1. Musculoskeletal infection in orthopaedic trauma: Assessment of the 2018 international consensus meeting on musculoskeletal infection

    Journal of Bone and Joint Surgery - American Volume, Vol. 102, Núm. 10, pp. E441-E449

2019

  1. Association between complications and death within 30 days after noncardiac surgery

    CMAJ, Vol. 191, Núm. 30, pp. E830-E837

  2. Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list

    The Lancet HIV, Vol. 6, Núm. 9, pp. e623-e631

  3. Rising rural body-mass index is the main driver of the global obesity epidemic in adults

    Nature

2018

  1. Early and highly suppressive antiretroviral therapy are main factors associated with low viral reservoir in European perinatally HIV-infected children

    Journal of Acquired Immune Deficiency Syndromes

  2. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation

    Journal of the International AIDS Society, Vol. 21, Núm. 11

2017

  1. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery

    JAMA - Journal of the American Medical Association, Vol. 317, Núm. 16, pp. 1642-1651

  2. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: A multiregional analysis from Southern Africa, West Africa and Europe

    International Journal of Epidemiology, Vol. 46, Núm. 2, pp. 453-465